Dr. Priyanka Bajaj, PhD, Editor is an Assistant Professor at the Department of Chemical Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Her group is working on the cutting-edge field of Biopharmaceutical Proteins and Enzymes. The group explores industrially important biopharmaceutical proteins like antibodies, antibody-drug conjugates (ADCs), and enzymes, including P450s, Ketoreductases, Transaminases, and others. She has 15 years of experience from her two post-doctorates at the University of Rochester, New York, and the University of Michigan, Ann Arbor, MI, USA, as well as in her PhD from NIPER, Mohali. She is the author and co-author of multiple reputed international research articles in reputed journals like Angewandte Chemie, Journal of Organic Chemistry, Biochemie and others and patents and has been awarded several national and international academic awards. She has supervised 15 master students by now and is currently supervising 08 masters and 06 PhD students. Dr. A. R. Satvik Iyengar, PhD, holds a Doctor of Philosophy degree in Medical Biochemistry from The University of Newcastle in Australia. Subsequent to his PhD he worked as a Scientific Writer in Cactus Communications in India. Prior to his PhD he graduated with a Masters in Science in Pharmaceutical Sciences from NIPER, S.A.S. Nagar in India and later worked as Junior Research fellow (JRF) at NIPER, S.A.S. Nagar. During his PhD he worked on understanding the effects of inflammation in Parkinson’s disease and during his MS and JRF tenure he has worked on Enzyme expression, purification and stabilization. He has been involved in writing scientific articles for more than a decade and has published several review and research articles. During his stint as a scientific writer for Cactus Communications he was also involved in writing medical information documents for various pharmaceutical companies that were aimed at informing health care professionals.

• 1. Introduction - Enzymes: Biomarkers, Targets and Therapy2. Enzymes in α-synucleinopathies: Biomarkers, Targets and Therapeutic molecules3. Enzymes as Biomarkers, Targets and Therapeutic molecules in Alzheimer’s disease4. Enzymes of relevance as biomarkers in cancers5. Enzymatic targets for drug discovery in cancers6. Enzymes as drug targets in diabetes7. Enzymes in lipid disorders8. Enzymes in Hypertensive disorders9. Enzymatic biomarkers in Cardiovascular Disorders10. Enzymes as biomarkers and therapeutic targets in Autoimmune Disorders11. Enzymes for treatment of bacterial diseases12. Mitigating the antimicrobial resistance through enzymes: The role of CRISPR-Cas9 gene editing

Dr. Priyanka Bajaj, PhD, Editor is an Assistant Professor at the Department of Chemical Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Her group is working on the cutting-edge field of Biopharmaceutical Proteins and Enzymes. The group explores industrially important biopharmaceutical proteins like antibodies, antibody-drug conjugates (ADCs), and enzymes, including P450s, Ketoreductases, Transaminases, and others. She has 15 years of experience from her two post-doctorates at the University of Rochester, New York, and the University of Michigan, Ann Arbor, MI, USA, as well as in her PhD from NIPER, Mohali. She is the author and co-author of multiple reputed international research articles in reputed journals like Angewandte Chemie, Journal of Organic Chemistry, Biochemie and others and patents and has been awarded several national and international academic awards. She has supervised 15 master students by now and is currently supervising 08 masters and 06 PhD students. Dr. A. R. Satvik Iyengar, PhD, holds a Doctor of Philosophy degree in Medical Biochemistry from The University of Newcastle in Australia. Subsequent to his PhD he worked as a Scientific Writer in Cactus Communications in India. Prior to his PhD he graduated with a Masters in Science in Pharmaceutical Sciences from NIPER, S.A.S. Nagar in India and later worked as Junior Research fellow (JRF) at NIPER, S.A.S. Nagar. During his PhD he worked on understanding the effects of inflammation in Parkinson’s disease and during his MS and JRF tenure he has worked on Enzyme expression, purification and stabilization. He has been involved in writing scientific articles for more than a decade and has published several review and research articles. During his stint as a scientific writer for Cactus Communications he was also involved in writing medical information documents for various pharmaceutical companies that were aimed at informing health care professionals.

• 1. Introduction - Enzymes: Biomarkers, Targets and Therapy2. Enzymes in α-synucleinopathies: Biomarkers, Targets and Therapeutic molecules3. Enzymes as Biomarkers, Targets and Therapeutic molecules in Alzheimer’s disease4. Enzymes of relevance as biomarkers in cancers5. Enzymatic targets for drug discovery in cancers6. Enzymes as drug targets in diabetes7. Enzymes in lipid disorders8. Enzymes in Hypertensive disorders9. Enzymatic biomarkers in Cardiovascular Disorders10. Enzymes as biomarkers and therapeutic targets in Autoimmune Disorders11. Enzymes for treatment of bacterial diseases12. Mitigating the antimicrobial resistance through enzymes: The role of CRISPR-Cas9 gene editing

Dr. Priyanka Bajaj, PhD, Editor is an Assistant Professor at the Department of Chemical Sciences at the National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, India. Her group is working on the cutting-edge field of Biopharmaceutical Proteins and Enzymes. The group explores industrially important biopharmaceutical proteins like antibodies, antibody-drug conjugates (ADCs), and enzymes, including P450s, Ketoreductases, Transaminases, and others. She has 15 years of experience from her two post-doctorates at the University of Rochester, New York, and the University of Michigan, Ann Arbor, MI, USA, as well as in her PhD from NIPER, Mohali. She is the author and co-author of multiple reputed international research articles in reputed journals like Angewandte Chemie, Journal of Organic Chemistry, Biochemie and others and patents and has been awarded several national and international academic awards. She has supervised 15 master students by now and is currently supervising 08 masters and 06 PhD students. Dr. A. R. Satvik Iyengar, PhD, holds a Doctor of Philosophy degree in Medical Biochemistry from The University of Newcastle in Australia. Subsequent to his PhD he worked as a Scientific Writer in Cactus Communications in India. Prior to his PhD he graduated with a Masters in Science in Pharmaceutical Sciences from NIPER, S.A.S. Nagar in India and later worked as Junior Research fellow (JRF) at NIPER, S.A.S. Nagar. During his PhD he worked on understanding the effects of inflammation in Parkinson’s disease and during his MS and JRF tenure he has worked on Enzyme expression, purification and stabilization. He has been involved in writing scientific articles for more than a decade and has published several review and research articles. During his stint as a scientific writer for Cactus Communications he was also involved in writing medical information documents for various pharmaceutical companies that were aimed at informing health care professionals.

• 1. Introduction - Enzymes: Biomarkers, Targets and Therapy2. Enzymes in α-synucleinopathies: Biomarkers, Targets and Therapeutic molecules3. Enzymes as Biomarkers, Targets and Therapeutic molecules in Alzheimer’s disease4. Enzymes of relevance as biomarkers in cancers5. Enzymatic targets for drug discovery in cancers6. Enzymes as drug targets in diabetes7. Enzymes in lipid disorders8. Enzymes in Hypertensive disorders9. Enzymatic biomarkers in Cardiovascular Disorders10. Enzymes as biomarkers and therapeutic targets in Autoimmune Disorders11. Enzymes for treatment of bacterial diseases12. Mitigating the antimicrobial resistance through enzymes: The role of CRISPR-Cas9 gene editing